title: [Testicular biopsy at the stopping of the treatment in acute lymphoblastic leukemia: value of the immunohistochemical detection of residual blasts].
abstract: BACKGROUND
  The prognostic value of clinical and histological detection of testicular leukemia after completion of therapy is still debated. Immunohistochemical study could improve the results of this detection.
  
  
  METHODS
  Between 1982 and 1992, 70 consecutive boys with acute lymphoblastic leukemia (ALL) and treated with the same therapeutic regimen were included in the study. Testicular biopsy (TB) was surgical and bilateral. One piece of tissue was fixed and analysed by conventional microscopy. An immunohistochemical study was performed on the other sample with a panel of anti-T and anti-B Mc Ab, including JCB 117 (anti-CD79a) which stains early pre B lymphoblasts.
  
  
  RESULTS
  Twenty-five children relapsed while on treatment and did not undergo TB. Among the 45 boys who underwent routine TB, one had a diffuse infiltration seen in conventional histology. Thirty-nine had normal morphological and immunohistochemical study: among them, six relapsed subsequently in bone marrow; in this group, event free survival (EFS) was 85 +/- 10% with a median follow-up of 80 months after the biopsy. In the five remaining boys, anti-CD79a was found positive on blasts in four cases and anti-CD3 in one case; four of those relapsed, including two in the testes during the year following the biopsy; EFS was 20 +/- 36% (P = 0.001).
  
  
  CONCLUSIONS
  New Mc Ab such as JCB 117 (anti-CD79a) might detect a minimal residual disease in the testes of children treated for ALL, particularly on routine histological material. These results, if confirmed in larger series, might influence further therapeutic strategy.
authors.affiliation: Unité d'hémato-oncologie pédiatrique, CHU Purpan, Toulouse, France.
authors.forename: K
authors.initials: K
authors.lastname: Imadalou
authors.forename: H
authors.initials: H
authors.lastname: Rubie
authors.forename: P
authors.initials: P
authors.lastname: Brousset
authors.forename: J
authors.initials: J
authors.lastname: Guitard
authors.forename: A
authors.initials: A
authors.lastname: Suc
authors.forename: M
authors.initials: M
authors.lastname: Delsol-Tahou
authors.forename: S
authors.initials: S
authors.lastname: Claeyssens
authors.forename: P
authors.initials: P
authors.lastname: Izard
authors.forename: A
authors.initials: A
authors.lastname: Robert
authors.forename: G
authors.initials: G
authors.lastname: Delsol
authors.forename: C
authors.initials: C
authors.lastname: Regnier
mesh_terms: D000293:Adolescent; D000911:Antibodies, Monoclonal; D015703:Antigens, CD / Q000276:immunology; D001706:Biopsy; D017252:CD3 Complex / Q000276:immunology; D051925:CD79 Antigens; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000473:pathology*; D011947:Receptors, Antigen, B-Cell / Q000276:immunology; D013737:Testis / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D017252:CD3 Complex; D051925:CD79 Antigens; C497881:CD79A protein, human; D011947:Receptors, Antigen, B-Cell
vernacular_title: Biopsie testiculaire à l'arrêt du traitement des leucémies aiguës lymphoblastiques: intérêt de la détection immunohistochimique des blastes résiduels.